FDA Warns Consumers Not to Use Skin Products Made by Clarcon Due to Bacterial Contamination Risk

Thanks to the Twitter from Kayla Fioravanti about this latest release from the FDA. Be sure to click over to the link to see the product labels of the products. from the FDA release FDA Warns Consumers Not to Use Skin Products Made by Clarcon Due to Bacterial Contamination Risk Products marketed under various names The U.S. Food and Drug Administration announced today that Clarcon Biological Chemistry Laboratory Inc. of Roy, Utah, is voluntarily recalling some skin sanitizers and skin protectants marketed under several different brand names because of high levels of disease-causing bacteria found in the product during a recent inspection. The FDA is warning consumers to not use any Clarcon products. Consumers should not use any Clarcon products and should throw these products away in household refuse. Analyses of several samples of over-the-counter topical antimicrobial skin sanitizer and skin protectant products revealed high levels of various bacteria, including some associated with unsanitary conditions. Some of these bacteria can cause opportunistic infections of the skin and underlying tissues. Such infections may need medical or surgical attention, and may result in permanent damage. Examples of products that should be discarded include: Citrushield Lotion Dermasentials DermaBarrier Dermassentials by Clarcon Antimicrobial Hand Sanitizer Iron Fist Barrier Hand Treatment Skin Shield Restaurant Skin Shield Industrial Skin Shield Beauty Salon Lotion Total Skin Care Beauty Total Skin Care Work Findings from the FDA’s recent inspection of the Clarcon facility are particularly conce ing because the products are promoted as antimicrobial agents that claim to treat open wounds, damaged skin, and protect against various infectious diseases. The inspection uncovered serious deviations from FDA’s current Good Manufacturing Practice requirements. Health care professionals and consumers may report serious adverse events (side effects) or product quality problems with the use of this product to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, fax or phone.